Cell line · CVCL_1635
Panc 03.27
Cancer cell line, Homo sapiens. Pancreatic adenocarcinoma. 31 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. Panc 03.27. Cell lines, record CVCL_1635. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1635
On this page
Cell line
As Cellosaurus gives it.
- Name
- Panc 03.27
- Accession
- CVCL_1635
- RRID
- RRID:CVCL_1635
- Synonyms
- Panc 3.27, Panc-03.27, PANC-03-27, Panc_03_27, Panc-3_27, PANC3.27, Panc3.27, Panc3_27, Panc-327, PANC 327, Panc327, PANC0327, Panc0327, PL11, PL-11
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 65Y
- Category
- Cancer cell line
- Diseases
- Pancreatic adenocarcinoma (NCIt C8294)
- Derived from
- Pancreas (in situ)
- Secondary accessions
- CVCL_H601
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers31
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| RBM15-Mediated m6A Modification Regulates Proliferation and Migration of Pancreatic Cancer Cells via the lncRNA LINC01320/miR-1287-5p/FBXO11 Axis. | Biomol Ther (Seoul) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| IFN-γ-driven UBE2D3 upregulation impairs antigen presentation pathways and anti-tumor immunity in pancreatic cancer. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilities. | Cell Rep Med | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Non-canonical functions of SNAIL drive context-specific cancer progression. | Nat Commun | 2023 | Its Methods give the RRID and name the line | PubMed | |
| A Novel B7-H6-Targeted IgG-Like T Cell-Engaging Antibody for the Treatment of Gastrointestinal Tumors. | Clin Cancer Res | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed | |
| Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells. | Cell Rep | 2022 | Its Methods give the RRID and name the line | PubMed | |
| DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer. | Clin Epigenetics | 2020 | Its Methods give the RRID and name the line | PubMed | |
| Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types. | Nat Commun | 2019 | Cellosaurus cites it | PubMed | |
| Next-generation characterization of the Cancer Cell Line Encyclopedia. | Nature | 2019 | Cellosaurus cites it | PubMed |
1 to 10 of 31
See all 31 papersRelatives5
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | 1.A16 | CVCL_E4F6 | Cell lines | |
| Derived from it | 1.A18 | CVCL_E4F7 | Cell lines | |
| Derived from it | 1.A21 | CVCL_E4F8 | Cell lines | |
| Derived from it | 1.B6 | CVCL_E4F9 | Cell lines | |
| Derived from it | 2.B2 | CVCL_E4FA | Cell lines |
Cell banks1
| Cell bank | Catalog number | Status |
|---|---|---|
| ATCC | CRL-2549 |
Source ATCC
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1635
GET https://conductscience.org/api/cell-lines/v1/CVCL_1635/papers?page=2